Avalo Therapeutics Inc (AVTX)
10.84
-0.65
(-5.66%)
USD |
NASDAQ |
May 10, 16:00
10.79
-0.05
(-0.46%)
After-Hours: 19:12
Avalo Therapeutics Market Cap: 11.21M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 11.88M |
| May 08, 2024 | 12.13M |
| May 07, 2024 | 13.70M |
| May 06, 2024 | 13.97M |
| May 03, 2024 | 14.85M |
| May 02, 2024 | 15.91M |
| May 01, 2024 | 16.55M |
| April 30, 2024 | 17.70M |
| April 29, 2024 | 17.46M |
| April 26, 2024 | 16.48M |
| April 25, 2024 | 15.49M |
| April 24, 2024 | 14.68M |
| April 23, 2024 | 13.44M |
| April 22, 2024 | 12.63M |
| April 19, 2024 | 12.03M |
| April 18, 2024 | 12.42M |
| April 17, 2024 | 14.08M |
| April 16, 2024 | 16.48M |
| April 15, 2024 | 15.76M |
| April 12, 2024 | 15.41M |
| April 11, 2024 | 16.29M |
| April 10, 2024 | 15.57M |
| April 09, 2024 | 14.97M |
| April 08, 2024 | 14.67M |
| April 05, 2024 | 16.96M |
| Date | Value |
|---|---|
| April 04, 2024 | 16.86M |
| April 03, 2024 | 16.87M |
| April 02, 2024 | 15.68M |
| April 01, 2024 | 18.51M |
| March 28, 2024 | 22.49M |
| March 27, 2024 | 4.912M |
| March 26, 2024 | 3.988M |
| March 25, 2024 | 4.174M |
| March 22, 2024 | 4.209M |
| March 21, 2024 | 3.968M |
| March 20, 2024 | 3.855M |
| March 19, 2024 | 3.752M |
| March 18, 2024 | 3.830M |
| March 15, 2024 | 3.769M |
| March 14, 2024 | 4.008M |
| March 13, 2024 | 4.425M |
| March 12, 2024 | 4.369M |
| March 11, 2024 | 4.506M |
| March 08, 2024 | 4.714M |
| March 07, 2024 | 4.201M |
| March 06, 2024 | 4.145M |
| March 05, 2024 | 3.608M |
| March 04, 2024 | 3.688M |
| March 01, 2024 | 3.544M |
| February 29, 2024 | 3.536M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.720M
Minimum
Sep 11 2023
47.25B
Maximum
Dec 24 2019
7.985B
Average
241.81M
Median
Market Cap Benchmarks
| Imunon Inc | 13.25M |
| iBio Inc | 6.516M |
| Kodiak Sciences Inc | 189.13M |
| Petros Pharmaceuticals Inc | 4.400M |
| Ocugen Inc | 409.15M |
Market Cap Related Metrics
| PS Ratio | 1.554 |
| Price to Book Value | 1.535 |
| Price | 10.84 |
| Earnings Yield | -3.53K% |